Cargando…

Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects

Obesity associates with reduced life expectancy, type 2 diabetes, hypertension and cardiovascular disease, and is characterized by chronic inflammation. Phosphorylcholine (PC) is an epitope on oxidized low-density lipoprotein, dead cells and some microorganisms. Antibodies against PC (anti-PC) have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jujić, Amra, Korduner, J., Holm, H., Engström, G., Bachus, E., Bhattacharya, P., Nilsson, P. M., Frostegård, Johan, Magnusson, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511239/ https://www.ncbi.nlm.nih.gov/pubmed/34642415 http://dx.doi.org/10.1038/s41598-021-99615-z

Ejemplares similares

Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project
por: Korduner, Johan, et al.
Publicado: (2022)

Physical Inactivity Is Associated With Post-discharge Mortality and Re-hospitalization Risk Among Swedish Heart Failure Patients—The HARVEST-Malmö Study
por: Zaghi, Amir, et al.
Publicado: (2022)

Galectin-4 is associated with diabetes and obesity in a heart failure population
por: Dieden, Anna, et al.
Publicado: (2023)

Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)

The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation—The HARVEST-Malmö study
por: Nezami, Zainu, et al.
Publicado: (2022)

Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort
por: Korduner, J., et al.
Publicado: (2021)

Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)

Cardiovascular biomarkers predict post‐discharge re‐hospitalization risk and mortality among Swedish heart failure patients
por: Molvin, John, et al.
Publicado: (2019)

IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
por: Frostegård, Anna G., et al.
Publicado: (2014)

Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality
por: Samal, S. K., et al.
Publicado: (2020)

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020)

Metabolically Healthy Obesity (MHO)—New Research Directions for Personalised Medicine in Cardiovascular Prevention
por: Nilsson, Peter M., et al.
Publicado: (2020)

The Shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST‐Malmö study
por: Xhakollari, Liana, et al.
Publicado: (2021)

Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022)

Autonomic dysfunction is associated with cardiac remodelling in heart failure patients
por: Ali, Amna, et al.
Publicado: (2017)

Cognitive test results are associated with mortality and rehospitalization in heart failure: Swedish prospective cohort study
por: Holm, Hannes, et al.
Publicado: (2020)

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms
por: Thiagarajan, D., et al.
Publicado: (2020)

Impaired cerebral oxygenation in heart failure patients at rest and during head‐up tilt testing
por: Kharraziha, Isabella, et al.
Publicado: (2020)

Atrial Natriuretic Peptide and Type 2 Diabetes Development – Biomarker and Genotype Association Study
por: Jujić, Amra, et al.
Publicado: (2014)

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea
por: Frostegård, Johan, et al.
Publicado: (2007)

Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2009)

Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases
por: de Vries, M. R., et al.
Publicado: (2021)

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events
por: Ajeganova, Sofia, et al.
Publicado: (2021)

How to calculate ventricular–arterial coupling?
por: Holm, Hannes, et al.
Publicado: (2022)

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
por: Anania, Cristina, et al.
Publicado: (2010)

Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2008)

Phosphorylcholine Allows for Evasion of Bactericidal Antibody by Haemophilus influenzae
por: Clark, Sarah E., et al.
Publicado: (2012)

Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019)

Metabolite Profiling in a Diet-Induced Obesity Mouse Model and Individuals with Diabetes: A Combined Mass Spectrometry and Proton Nuclear Magnetic Resonance Spectroscopy Study
por: Vieira, João P. P., et al.
Publicado: (2023)

A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population – the Malmö preventive project study
por: Jujić, Amra, et al.
Publicado: (2013)

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
por: Silajdžić, Edina, et al.
Publicado: (2015)

Targeting Phosphorylcholine in Established Atherosclerosis?
por: Tsiantoulas, Dimitrios
Publicado: (2020)

CLONAL NATURE OF THE IMMUNE RESPONSE TO PHOSPHORYLCHOLINE : I. SPECIFICITY, CLASS, AND IDIOTYPE OF PHOSPHORYLCHOLINE-BINDING RECEPTORS ON LYMPHOID CELLS
por: Claflin, J. Latham, et al.
Publicado: (1974)

Analysis of Bacterial Phosphorylcholine-Related Genes Reveals an Association between Type-Specific Biosynthesis Pathways and Biomolecules Targeted for Phosphorylcholine Modification
por: Zhang, Yuan, et al.
Publicado: (2023)

Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae
Publicado: (1982)

Plasma Galectin-4 Levels Are Increased after Stroke in Mice and Humans
por: Jujic, Amra, et al.
Publicado: (2023)

Elicitation of delayed-type hypersensitivity to phosphorylcholine by monoclonal anti-idiotypic antibodies in an allogeneic environment
Publicado: (1982)

Site-oriented conjugation of poly(2-methacryloyloxyethyl phosphorylcholine) for enhanced brain delivery of antibody
por: Ren, Jie, et al.
Publicado: (2023)

Exploring biomarkers associated with deteriorating vascular health using a targeted proteomics chip: The SABPA study
por: Dieden, Anna, et al.
Publicado: (2021)

Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts
por: Baganha, Fabiana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aocj6rrk4uofcbost65c606e86